Chemical Structure : CUDC-101
CAS No.: 1012054-59-9
货号: PC-42467Not For Human Use, Lab Use Only.
CUDC-101 (CUDC101) is a potent, multi-targeted HDAC, EGFR and HER2 inhibitor with IC50 of 4.4, 2.4, and 15.7 nM, respectively.
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 10 mg | ¥780 | In stock | |
| 25 mg | ¥1280 | In stock | |
| 50 mg | ¥1980 | In stock | |
| 100 mg | ¥3280 | In stock | |
| 250 mg | Get quote | 
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
	CUDC-101 (CUDC101) is a potent, multi-targeted HDAC, EGFR and HER2 inhibitor with IC50 of 4.4, 2.4, and 15.7 nM, respectively.
	CUDC-101 exhibits efficient antiproliferative activity with greater potency (IC50<1 uM) than Vorinostat (SAHA), Erlotinib, Lapatinib.
	CUDC-101 promotes tumor regression or inhibition in various cancer xenograft models including NSCLC, liver, breast, head and neck, colon, and pancreatic cancers.
| 分子量 | 434.4876 | |
| 分子式 | C24H26N4O4 | |
| 外观性状 | Solid | |
| 储存条件 | 
                            
  | 
                        
                            
  | 
                    
| Solubility | 
                             10 mM in DMSO  | 
                    |
| Chemical Name/SMILES | 
                             Heptanamide, 7-[[4-[(3-ethynylphenyl)amino]-7-methoxy-6-quinazolinyl]oxy]-N-hydroxy-  | 
                    |
1. Cai X, et al. J Med Chem. 2010 Mar 11;53(5):2000-9.
2. Lai CJ, et al. Cancer Res. 2010 May 1;70(9):3647-56.
3. Wang J, et al. Mol Cancer Ther. 2013 Jun;12(6):925-36.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright